Originator Organization A2a Pharmaceuticals, Inc.Startup |
Active Organization A2a Pharmaceuticals, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | A2a Pharmaceuticals, Inc.Startup | 29 Mar 2022 |